NCT01760655 Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies Status COMPLETED Phase PHASE2
NCT01754389 Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT01745159 Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT01707004 Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT01702181 A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT01701986 Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT01680861 Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium Status COMPLETED Phase PHASE3
NCT01664910 CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT01659606 Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01655563 Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation Status COMPLETED Phase PHASE2
NCT01652014 Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies Status WITHDRAWN Phase PHASE2
NCT01625377 A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients Status COMPLETED Phase PHASE3
NCT01621477 T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant Status TERMINATED Phase PHASE2
NCT01614665 A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time Status COMPLETED Phase PHASE2